1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (6438)
  2. Meeting Abstract (5172)
  3. Review (332)
  4. Book Section (310)
  5. Editorial (92)
  6. Research Letter (73)
  7. Guidelines (52)
  8. Correspondence (47)
  9. Conference Paper (38)
  10. Miscellaneous (37)
  11. Book Whole (24)
Groups
  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Victor Reuter (1228)
  3. Cristina Antonescu (895)
  4. Michael Berger (765)
  5. William Travis (743)
  6. Jinru Shia (719)

More People

Years
  1. 2025 (307)
  2. 2024 (719)
  3. 2023 (766)
  4. 2022 (841)
  5. 2021 (677)
  6. 2020 (787)

More Years

Publications
  1. Laboratory Investigation (1448)
  2. Modern Pathology (1440)
  3. Journal of Clinical Oncology (863)
  4. American Journal of Surgical Pathology (429)
  5. Cancer Research (426)
  6. Blood (349)

More Publications

Publishers
  1. Nature Publishing Group (1939)
  2. Nature Research (1457)
  3. Elsevier Inc. (1139)
  4. American Society of Clinical Oncology (955)
  5. American Association for Cancer Research (923)
  6. Lippincott Williams & Wilkins (896)

More Publishers

Results (12615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The paradoxical behavior of Kappa when quantifying agreement in histological subtype classification among thoracic pathologists
    Meeting Abstract

    Tan, K. S.; Adusumilli, P.; Travis, W. D.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry
    Meeting Abstract

    Carrot-Zhang, J.; Fong, C.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with EGFR-mutant lung cancer with acquired BRAF alterations
    Meeting Abstract

    Sui, J.; Yang, S. R.; Bowman, A. S.; Vankayala, P.; Falcon, C.; Somwar, R.; Drilon, A. E.; Riely, G. J.; Kris, M. G.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Microsatellite instability defines a subset of lung cancers with smoking exposure, high tumor mutational burden and MLH1 inactivation
    Meeting Abstract

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benhamida, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • The International Association for the Study of Lung Cancer grading system for recurrence and lung cancer-specific survival
    Meeting Abstract

    Tan, K. S.; Reiner, A.; Emoto, K.; Aly, R. G.; Rekhtman, N.; Adusumilli, P.; Travis, W.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Acquired melanocytic nevi mimicking acral lentiginous melanoma in a patient taking a BRAF inhibitor
    Journal Article

    Nazir, Z. H.; Haliasos, H. C.; Busam, K. J.; Marchetti, M. A.; Linos, K.; Marghoob, A. A.
    JAMA Dermatology (2023)

    Fulltext@MSK | Save
  • Virtual surgical planning and three-dimensional models for precision sinonasal and skull base surgery
    Journal Article

    Fitzgerald, C. W.; Hararah, M.; McLean, T.; Woods, R.; Dogan, S.; Tabar, V.; Ganly, I.; Matros, E.; Cohen, M. A.
    Cancers (2023)

    Fulltext@MSK | Save
  • Current laboratory testing practices for assessment of ERBB2/HER2 in endometrial serous carcinoma and colorectal carcinoma
    Journal Article

    Hagemann, I. S.; Bridge, J. A.; Tafe, L. J.; Hameed, M. R.; Moncur, J. T.; Bellizzi, A. M.; Dolan, M.; Vasalos, P.; Kane, M. E.; Souers, R. J.; more...
    Archives of Pathology & Laboratory Medicine (2023)

    Fulltext@MSK | Save
  • Vepafestinib: a RET-selective inhibitor with enhanced CNS penetrance targets therapy-resistant mutants
    Editorial

    Odintsov, I.; Somwar, R.
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Comprehensive molecular characterization of polymorphous adenocarcinoma, cribriform subtype: Identifying novel fusions and fusion partners
    Journal Article

    Hahn, E.; Xu, B.; Katabi, N.; Dogan, S.; Smith, S. M.; Perez-Ordonez, B.; Patel, P. B.; Macmillan, C.; Lubin, D. J.; Gagan, J.; more...
    Modern Pathology (2023)

    Fulltext@MSK | Save